Active Supportive Care and Symptom Management Grants

PI Namesort descending Organization - Company Title Major Program / Research Group FOA
Accordino, Melissa Columbia University Health Sciences Cryotherapy and Compression Therapy to Prevent Chemotherapy Induced Peripheral Neuropathy in Breast Cancer Patients Community Oncology and Prevention Trials, Neuropathy PAR-18-021
Dougherty, Patrick M University Of Tx Md Anderson Can Ctr The role of ENF loss, TLR4 and spinal plasticity in paclitaxel CIPN Community Oncology and Prevention Trials, Neuropathy PA-13-302
Gewandter, Jennifer University Of Rochester Wireless transcutaneous electrical stimulation (TENS) for chemotherapy-induced peripheral neuropathy: A phase II randomized clinical trial Community Oncology and Prevention Trials, Neuropathy, Pain PA-18-159
Levine, Jon David University Of California, San Francisco Chronic Chemotherapy Peripheral Neuropathy: Role of Neuroplasticity and Stress Community Oncology and Prevention Trials, Neuropathy
Lustberg, Maryam B Ohio State University Prevention of paclitaxel-induced peripheral neuropathy with nilotinib Community Oncology and Prevention Trials, Provocative Questions, Neuropathy RFA-CA-18-019
Melemedjian, Ohannes Kevork University Of Maryland Baltimore Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy Community Oncology and Prevention Trials, Neuropathy RFA-NS-18-043
Romero-Sandoval, E. Alfonso Wake Forest University Health Sciences IRE1a-XBP1 Signaling as a Driver of Chemotherapy-Induced Peripheral Neuropathy Community Oncology and Prevention Trials, Neuropathy, Other Supportive Care Issues PA-16-258
Salvemini, Daniela Saint Louis University A3AR agonists as a novel approach to mitigate chemotherapy induced neurotoxicity Community Oncology and Prevention Trials, Neuropathy PAR-16-275
Smith, Ellen Mary Lavoie University Of Michigan At Ann Arbor Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Bind, Placebo-Controlled Phase II to Phase III Study Community Oncology and Prevention Trials, Neuropathy PAR-18-559
Staff, Nathan P Mayo Clinic Rochester Assessment of Chemotherapy-Induced Peripheral Neuropathy Susceptibility Using Patient-derived iPSC Technology Community Oncology and Prevention Trials, Neuropathy PA-16-160
Visovsky, Constance G. University Of South Florida Home-Based Physical Activity Intervention for Taxane-Induced CIPN Community Oncology and Prevention Trials, Neuropathy PAR-18-559
Winters-Stone, Kerri M Oregon Health & Science University Patterns and predictors of symptoms, falls, and functioning across treatment and recovery in patients treated with neurotoxic chemotherapy for cancer Community Oncology and Prevention Trials, Neuropathy PA-19-056
Yeh, Chao Hsing Johns Hopkins University Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy Community Oncology and Prevention Trials, Neuropathy, Pain PA-18-141